Provided by Tiger Trade Technology Pte. Ltd.

CRMI

0.320
+0.0103.23%
Volume:80.00K
Turnover:26.48K
Market Cap:97.28M
PE:3.54
High:0.355
Open:0.355
Low:0.320
Close:0.310
52wk High:1.200
52wk Low:0.240
Shares:304.00M
HK Float Shares:304.00M
Volume Ratio:0.16
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.091
ROE:69.97%
ROA:6.75%
PB:1.82
PE(LYR):3.54
PS:1.35

Loading ...

CRMI Posts 55.1% Profit Surge in FY2025 Amid 20.5% Revenue Slide; Leverage and Liquidity Improve but Going-Concern Risk Highlighted

Bulletin Express
·
Mar 30

CRMI Reports Fiscal Year Profit Surge of 55.05% to HK$27.525 Million

Stock News
·
Mar 28

CRMI FY2025 Results: Net Profit Jumps 55% to HK$27.53 Million as Tax Credit Offsets 20% Revenue Slide

Bulletin Express
·
Mar 27

China Regenerative Medicine International FY2025 profit rises to HK$27.53 million; revenue drops 20.48% to HK$72.06 million

Reuters
·
Mar 27

China Regenerative Medicine International FY Net Income Attributable HKD 27.5 Million

THOMSON REUTERS
·
Mar 27

CRMI anticipates at least 28% jump in FY2025 attributable profit driven by tax credit

Bulletin Express
·
Mar 25

CRMI Issues Profit Alert, Anticipates Minimum 28% Rise in Annual Net Profit Attributable to Shareholders for 2025

Stock News
·
Mar 25

China Regenerative Medicine International FY2025 profit attributable to owners rises at least 28% due to income tax credit from prior-year overprovision

Reuters
·
Mar 25

China Regenerative Medicine International - Expected Increase in Profit Mainly Due to Income Tax Credit Recognized in FY2025

THOMSON REUTERS
·
Mar 25

Obagi Medical partners with ProMD Health in ALOHA Program to evaluate saypha MagIQ

Reuters
·
Mar 19

CRMI (08158) Sets 27 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend

Bulletin Express
·
Mar 16

UK’s Waldencast posts flat Q4 revenue on Milk Makeup weakness, withholds outlook

Reuters
·
Mar 13

China Regenerative Medicine International (08158) Reports Monthly Return for February 2026

Bulletin Express
·
Mar 02

Waldencast's Obagi and Schweiger Dermatology launch ALOHA Phase 4 study of saypha MagIQ injectable

Reuters
·
Feb 27

Obagi Medical Partners With It’s a Secret Med Spa in ALOHA Program for saypha MagIQ

Reuters
·
Feb 25

Waldencast Partners with Aesthetic Record for Obagi ALOHA Program

Reuters
·
Feb 17

Waldencast Partners with Moxie to Launch ALOHA Real-World Evidence Program

Reuters
·
Feb 05

China Regenerative Medicine International Limited (08158) Announces January 2026 Securities Movements

Bulletin Express
·
Feb 02

Waldencast Teams Up with VIO Med Spa for Obagi ALOHA Program

Reuters
·
Jan 30

Waldencast Partners with Next Health for Obagi ALOHA Program

Reuters
·
Jan 28